Cargando…

Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials

Lysophosphatidic acid (LPA) is a bioactive lipid mediator primarily derived from membrane phospholipids. LPA initiates cellular effects upon binding to a family of G protein-coupled receptors, termed LPA receptors (LPAR1 to LPAR6). LPA signaling drives cell migration and proliferation, cytokine prod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yu-Hsuan, Lin, Yueh-Chien, Chen, Chien-Chin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306951/ https://www.ncbi.nlm.nih.gov/pubmed/34209775 http://dx.doi.org/10.3390/cells10071629

Ejemplares similares

Mechanisms of Lysophosphatidic Acid-Mediated Lymphangiogenesis in Prostate Cancer
por: Wu, Pei-Yi, et al.
Publicado: (2018)

Lysophosphatidic acid receptor LPA(3) prevents oxidative stress and cellular senescence in Hutchinson–Gilford progeria syndrome
por: Chen, Wei‐Min, et al.
Publicado: (2019)

Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases
por: Xiang, Hongjiao, et al.
Publicado: (2020)

Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis
por: Lin, Kuan-Hung, et al.
Publicado: (2016)

The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis
por: Kim, Grace Hyun J., et al.
Publicado: (2021)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)

Lysophosphatidic Acid Enhances Vascular Endothelial Growth Factor-C Expression in Human Prostate Cancer PC-3 Cells
por: Lin, Chuan-En, et al.
Publicado: (2012)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH models
por: Bhattacharjee, Jashdeep, et al.
Publicado: (2023)

Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
por: Ma, Lin, et al.
Publicado: (2009)

Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
por: Tigyi, Gábor, et al.
Publicado: (2021)

In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay
por: Ruzza, C., et al.
Publicado: (2023)

Lysophosphatidic Acid and Hematopoiesis: From Microenvironmental Effects to Intracellular Signaling
por: Lin, Kuan-Hung, et al.
Publicado: (2020)

Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo
por: Yu, Zi-Li, et al.
Publicado: (2018)

Lysophosphatidic Acid Signaling in Cancer
por: Brindley, David N.
Publicado: (2020)

Effect of lysophosphatidic acid on the follicular development and the expression of lysophosphatidic acid receptor genes during in vitro culture of mouse ovary
por: Abedpour, Neda, et al.
Publicado: (2018)

Discovery of Chemical Scaffolds as Lysophosphatidic Acid Receptor 1 Antagonists: Virtual Screening, In Vitro Validation, and Molecular Dynamics Analysis
por: Nguyen, Lan Phuong, et al.
Publicado: (2023)

Regulation of Tumor Immunity by Lysophosphatidic Acid
por: Lee, Sue Chin, et al.
Publicado: (2020)

Activation of Lysophosphatidic Acid Receptor Is Coupled to Enhancement of Ca(2+)-Activated Potassium Channel Currents
por: Choi, Sun-Hye, et al.
Publicado: (2013)

Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid–lysophosphatidic acid receptor 1 cascade
por: Miyabe, Yoshishige, et al.
Publicado: (2014)

The autotaxin-lysophosphatidic acid–lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
por: Tabuchi, Sadaharu
Publicado: (2015)

Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA(2)), UCM-14216, Ameliorates Spinal Cord Injury in Mice
por: Khiar-Fernández, Nora, et al.
Publicado: (2022)

Lysophosphatidic Acid and Glutamatergic Transmission
por: Roza, Carolina, et al.
Publicado: (2019)

Diverse Effects of Lysophosphatidic Acid Receptors on Ovarian Cancer Signaling Pathways
por: Onallah, Hadil, et al.
Publicado: (2019)

Enhancement of P2X3 Receptor-Mediated Currents by Lysophosphatidic Acid in Rat Primary Sensory Neurons
por: Qiao, Wen-Long, et al.
Publicado: (2022)

Expression of lysophosphatidic acid receptors in the human lower esophageal sphincter
por: FENG, YONG, et al.
Publicado: (2014)

Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis
por: Miyabe, Chie, et al.
Publicado: (2019)

Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5
por: Wang, Mo, et al.
Publicado: (2021)

KA-1002, a Novel Lysophosphatidic Acid Signaling Antagonist, Alleviates Bovine Tracheal Cell Disruption and Inflammation
por: Shin, Hee-su, et al.
Publicado: (2020)

G-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT Signaling
por: Riaz, Anjum, et al.
Publicado: (2016)

Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice
por: Park, Eunhye, et al.
Publicado: (2017)

Lysophosphatidic acid in carcinogenesis and tumor development
por: Albrecht, Wiebke
Publicado: (2018)

Lysophosphatidic Acid Signaling in Diabetic Nephropathy
por: Lee, Jong Han, et al.
Publicado: (2019)

Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells
por: Plastira, Ioanna, et al.
Publicado: (2019)

Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway
por: Won, Kyung-Jong, et al.
Publicado: (2020)

Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2
por: YANG, DEZHI, et al.
Publicado: (2013)

Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness
por: Jeong, Bo Young, et al.
Publicado: (2021)

Peripheral mechanisms of neuropathic pain – involvement of lysophosphatidic acid receptor-mediated demyelination
por: Ueda, Hiroshi
Publicado: (2008)

Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
por: Kitayama, Joji, et al.
Publicado: (2004)

Lysophosphatidic Acid Receptor Is a Functional Marker of Adult Hippocampal Precursor Cells
por: Walker, Tara L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g2am8vj1lg08c1o3bo4gt0nmmr